Clinical features and prognosis of malignant small bowel tumors: Experience from a university hospital in Chile
dc.contributor.author | Silva, Felipe | |
dc.contributor.author | Bustamante, Miguel | |
dc.contributor.author | Latorre, Gonzalo | |
dc.contributor.author | Flandez, Jorge | |
dc.contributor.author | Montero, Isabella | |
dc.contributor.author | Dukes, Eitan | |
dc.contributor.author | Gandara, Vicente | |
dc.contributor.author | Robles, Camila | |
dc.contributor.author | Uribe, Javier | |
dc.contributor.author | Iglesias, Andres | |
dc.contributor.author | Bellolio, Felipe | |
dc.contributor.author | Molina, Maria Elena | |
dc.contributor.author | Migueles, Rodrigo | |
dc.contributor.author | Urrejola, Gonzalo | |
dc.contributor.author | Larach, Tomas | |
dc.contributor.author | Besser, Nicolas | |
dc.contributor.author | Sharp, Allan | |
dc.contributor.author | Aguero, Carlos | |
dc.contributor.author | Riquelme, Arnoldo | |
dc.contributor.author | Vargas, Jose Ignacio | |
dc.contributor.author | Candia, Roberto | |
dc.contributor.author | Monrroy, Hugo | |
dc.contributor.author | De Simone, Federico | |
dc.contributor.author | Espino, Alberto | |
dc.date.accessioned | 2025-01-20T16:17:14Z | |
dc.date.available | 2025-01-20T16:17:14Z | |
dc.date.issued | 2024 | |
dc.description.abstract | Background: Small bowel tumors (SBT) are infrequent and represent a small proportion of digestive neoplasms. There is scarce information about SBT in Latin America. Aim: To describe the epidemiology, clinical characteristics, diagnostic methods, and survival of malignant SBTs. Methods: Retrospective observational study of adult patients with histopathological diagnosis of SBT between 2007 and 2021 in a university hospital in Chile. Results: A total of 104 patients [51.9% men; mean age 57 years] with SBT. Histological type: neuroendocrine tumor (NET) (43.7%, n = 38), gastrointestinal stromal tumors (GIST) (21.8%, n = 19), lymphoma (17.2%, n = 15) and adenocarcinoma (AC) (11.5%, n = 10). GIST was more frequent in duodenum (50%; n = 12) and NET in the ileum (65.8%; n = 25). Metastasis was observed in 17 cases, most commonly from colon and melanoma. Nausea and vomiting were significantly more often observed in AC ( p = 0.035), as well as gastrointestinal bleeding in GIST ( p = 0.007). The most common diagnostic tools were CT and CT enteroclysis with an elevated diagnostic yield (86% and 94% respectively). The 5 -year survival of GIST, NET, lymphoma and AC were 94.7% (95%CI: 68.1 - 99.2), 82.2% (95%CI: 57.6 - 93.3), 40.0% (95%CI: 16.5 - 82.8) and 25.9% (95%CI: 4.5 - 55.7%), respectively. NET (HR 6.1; 95%CI: 2.1 - 17.2) and GIST (HR 24.4; 95%CI: 3.0 - 19.8) were independently associated with higher survival compared to AC, adjusted for age and sex. Conclusions: Malignant SBT are rare conditions and NETs are the most common histological subtype. Clinical presentation at diagnosis, location or complications may suggest a more probable diagnosis. GIST and NET are associated with better survival compared to other malignant subtypes. (c) 2024 Elsevier Espana, S.L.U. All rights reserved. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1016/j.gastrohep.2024.01.013 | |
dc.identifier.issn | 0210-5705 | |
dc.identifier.uri | https://doi.org/10.1016/j.gastrohep.2024.01.013 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/90587 | |
dc.identifier.wosid | WOS:001236422600001 | |
dc.issue.numero | 5 | |
dc.language.iso | en | |
dc.pagina.final | 499 | |
dc.pagina.inicio | 491 | |
dc.revista | Gastroenterologia y hepatologia | |
dc.rights | acceso restringido | |
dc.subject | Small bowel adenocarcinoma | |
dc.subject | Neuroendocrine tumors | |
dc.subject | Gastrointestinal stromal tumors | |
dc.subject | Enteroclysis | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Clinical features and prognosis of malignant small bowel tumors: Experience from a university hospital in Chile | |
dc.type | artículo | |
dc.volumen | 47 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |